APO RESEARCH · REPORT
Autoimmunity Reagents
Autoimmune diseases refer to diseases caused by the body's immune response to self-antigens, resulting in damage to its own tissues. Common autoimmune diseases include rheumatoid arthritis, systemic lupus erythematosus and vasculitis.
Product & engineering
Understand the product.
Autoimmune diseases refer to diseases caused by the body's immune response to self-antigens, resulting in damage to its own tissues. Common autoimmune diseases include rheumatoid arthritis, systemic lupus erythematosus and vasculitis.
Selected research
Industry Research
Autoimmunity Reagents Industry Research Report 2026
Market perspective
Autoimmune diseases refer to diseases caused by the body's immune response to self-antigens, resulting in damage to its own tissues. Common autoimmune diseases include rheumatoid arthritis, systemic lupus erythematosus and vasculitis.
According to the regional perspective, the market of Autoimmunity Reagents can be divided into North America, Europe, Japan, China, etc. in 2019, the market share of Europe is the highest, accounting for about 43%, of which the Asia Pacific region is the main growth pole of the commodity consumption.
EUROIMMUN、HUMAN、Bio-Rad Laboratories are the key manufacturers in the Global Autoimmunity Reagents Production Market. Top 3 totally took up nearly 50% of the global market in 2019, among which EUROIMMUN is the leader with a market share of over 29%.
Read the full market overview
Report Scope
This report quantifies the global Autoimmunity Reagents market in terms of revenue (US$ million) and, where applicable, sales volume (K Unit), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Unit) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Autoimmunity Reagents Market by Company
EUROIMMUN
HUMAN
Bio-Rad Laboratories
AESKU
Inova
MBL
Orgentec
Trinity
Phadia
HOB Biotech
Shenzhen YHLO Biotech
Kangrun Biotech
Immuno-Biological Laboratories
Biomedical diagnostics
Shanghai Kexin
Autoimmunity Reagents Segment by Type
BLOT
ELISA
IFA
CLIA
Autoimmunity Reagents Segment by Application
Hospital
Third-Party Testing Agency
Autoimmunity Reagents Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autoimmunity Reagents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Autoimmunity Reagents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autoimmunity Reagents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Autoimmunity Reagents manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Autoimmunity Reagents by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Autoimmunity Reagents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- BLOT
- ELISA
- IFA
- CLIA
Applications
- Hospital
- Third-Party Testing Agency
Companies covered
- EUROIMMUN
- HUMAN
- Bio-Rad Laboratories
- AESKU
- Inova
- MBL
- Orgentec
- Trinity
- Phadia
- HOB Biotech
- Shenzhen YHLO Biotech
- Kangrun Biotech
- Immuno-Biological Laboratories
- Biomedical diagnostics
- Shanghai Kexin
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Autoimmunity Reagents Market Size (2021-2032)
- 2.2.2 Global Autoimmunity Reagents Sales (2021-2032)
- 2.2.3 Global Autoimmunity Reagents Market Average Price (2021-2032)
- 2.3 Autoimmunity Reagents by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 BLOT
- 2.3.3 ELISA
- 2.3.4 IFA
- 2.3.5 CLIA
- 2.4 Autoimmunity Reagents by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Third-Party Testing Agency
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Autoimmunity Reagents Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Autoimmunity Reagents Sales (K Unit) of Manufacturers (2021-2026)
- 3.3 Global Autoimmunity Reagents Revenue of Manufacturers (2021-2026)
- 3.4 Global Autoimmunity Reagents Average Price by Manufacturers (2021-2026)
- 3.5 Global Autoimmunity Reagents Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Autoimmunity Reagents, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Autoimmunity Reagents, Product Type & Application
- 3.8 Global Manufacturers of Autoimmunity Reagents, Established Date
- 3.9 Global Autoimmunity Reagents Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 EUROIMMUN
- 4.1.1 EUROIMMUN Company Information
- 4.1.2 EUROIMMUN Business Overview
- 4.1.3 EUROIMMUN Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 EUROIMMUN Autoimmunity Reagents Product Portfolio
- 4.1.5 EUROIMMUN Recent Developments
- 4.2 HUMAN
- 4.2.1 HUMAN Company Information
- 4.2.2 HUMAN Business Overview
- 4.2.3 HUMAN Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 HUMAN Autoimmunity Reagents Product Portfolio
- 4.2.5 HUMAN Recent Developments
- 4.3 Bio-Rad Laboratories
- 4.3.1 Bio-Rad Laboratories Company Information
- 4.3.2 Bio-Rad Laboratories Business Overview
- 4.3.3 Bio-Rad Laboratories Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bio-Rad Laboratories Autoimmunity Reagents Product Portfolio
- 4.3.5 Bio-Rad Laboratories Recent Developments
- 4.4 AESKU
- 4.4.1 AESKU Company Information
- 4.4.2 AESKU Business Overview
- 4.4.3 AESKU Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 AESKU Autoimmunity Reagents Product Portfolio
- 4.4.5 AESKU Recent Developments
- 4.5 Inova
- 4.5.1 Inova Company Information
- 4.5.2 Inova Business Overview
- 4.5.3 Inova Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Inova Autoimmunity Reagents Product Portfolio
- 4.5.5 Inova Recent Developments
- 4.6 MBL
- 4.6.1 MBL Company Information
- 4.6.2 MBL Business Overview
- 4.6.3 MBL Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 MBL Autoimmunity Reagents Product Portfolio
- 4.6.5 MBL Recent Developments
- 4.7 Orgentec
- 4.7.1 Orgentec Company Information
- 4.7.2 Orgentec Business Overview
- 4.7.3 Orgentec Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Orgentec Autoimmunity Reagents Product Portfolio
- 4.7.5 Orgentec Recent Developments
- 4.8 Trinity
- 4.8.1 Trinity Company Information
- 4.8.2 Trinity Business Overview
- 4.8.3 Trinity Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Trinity Autoimmunity Reagents Product Portfolio
- 4.8.5 Trinity Recent Developments
- 4.9 Phadia
- 4.9.1 Phadia Company Information
- 4.9.2 Phadia Business Overview
- 4.9.3 Phadia Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Phadia Autoimmunity Reagents Product Portfolio
- 4.9.5 Phadia Recent Developments
- 4.10 HOB Biotech
- 4.10.1 HOB Biotech Company Information
- 4.10.2 HOB Biotech Business Overview
- 4.10.3 HOB Biotech Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 HOB Biotech Autoimmunity Reagents Product Portfolio
- 4.10.5 HOB Biotech Recent Developments
- 4.11 Shenzhen YHLO Biotech
- 4.11.1 Shenzhen YHLO Biotech Company Information
- 4.11.2 Shenzhen YHLO Biotech Business Overview
- 4.11.3 Shenzhen YHLO Biotech Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Shenzhen YHLO Biotech Autoimmunity Reagents Product Portfolio
- 4.11.5 Shenzhen YHLO Biotech Recent Developments
- 4.12 Kangrun Biotech
- 4.12.1 Kangrun Biotech Company Information
- 4.12.2 Kangrun Biotech Business Overview
- 4.12.3 Kangrun Biotech Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Kangrun Biotech Autoimmunity Reagents Product Portfolio
- 4.12.5 Kangrun Biotech Recent Developments
- 4.13 Immuno-Biological Laboratories
- 4.13.1 Immuno-Biological Laboratories Company Information
- 4.13.2 Immuno-Biological Laboratories Business Overview
- 4.13.3 Immuno-Biological Laboratories Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Immuno-Biological Laboratories Autoimmunity Reagents Product Portfolio
- 4.13.5 Immuno-Biological Laboratories Recent Developments
- 4.14 Biomedical diagnostics
- 4.14.1 Biomedical diagnostics Company Information
- 4.14.2 Biomedical diagnostics Business Overview
- 4.14.3 Biomedical diagnostics Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Biomedical diagnostics Autoimmunity Reagents Product Portfolio
- 4.14.5 Biomedical diagnostics Recent Developments
- 4.15 Shanghai Kexin
- 4.15.1 Shanghai Kexin Company Information
- 4.15.2 Shanghai Kexin Business Overview
- 4.15.3 Shanghai Kexin Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Shanghai Kexin Autoimmunity Reagents Product Portfolio
- 4.15.5 Shanghai Kexin Recent Developments
5 Global Autoimmunity Reagents Market Scenario by Region
- 5.1 Global Autoimmunity Reagents Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Autoimmunity Reagents Sales by Region: 2021-2032
- 5.2.1 Global Autoimmunity Reagents Sales by Region: 2021-2026
- 5.2.2 Global Autoimmunity Reagents Sales by Region: 2027-2032
- 5.3 Global Autoimmunity Reagents Revenue by Region: 2021-2032
- 5.3.1 Global Autoimmunity Reagents Revenue by Region: 2021-2026
- 5.3.2 Global Autoimmunity Reagents Revenue by Region: 2027-2032
- 5.4 North America Autoimmunity Reagents Market Facts & Figures by Country
- 5.4.1 North America Autoimmunity Reagents Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Autoimmunity Reagents Sales by Country (2021-2032)
- 5.4.3 North America Autoimmunity Reagents Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Autoimmunity Reagents Market Facts & Figures by Country
- 5.5.1 Europe Autoimmunity Reagents Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Autoimmunity Reagents Sales by Country (2021-2032)
- 5.5.3 Europe Autoimmunity Reagents Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Autoimmunity Reagents Market Facts & Figures by Country
- 5.6.1 Asia Pacific Autoimmunity Reagents Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Autoimmunity Reagents Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Autoimmunity Reagents Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Autoimmunity Reagents Market Facts & Figures by Country
- 5.7.1 South America Autoimmunity Reagents Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Autoimmunity Reagents Sales by Country (2021-2032)
- 5.7.3 South America Autoimmunity Reagents Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Autoimmunity Reagents Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Autoimmunity Reagents Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Autoimmunity Reagents Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Autoimmunity Reagents Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Autoimmunity Reagents Sales by Type (2021-2032)
- 6.1.1 Global Autoimmunity Reagents Sales by Type (2021-2032) & (K Unit)
- 6.1.2 Global Autoimmunity Reagents Sales Market Share by Type (2021-2032)
- 6.2 Global Autoimmunity Reagents Revenue by Type (2021-2032)
- 6.2.1 Global Autoimmunity Reagents Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Autoimmunity Reagents Revenue Market Share by Type (2021-2032)
- 6.3 Global Autoimmunity Reagents Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Autoimmunity Reagents Sales by Application (2021-2032)
- 7.1.1 Global Autoimmunity Reagents Sales by Application (2021-2032) & (K Unit)
- 7.1.2 Global Autoimmunity Reagents Sales Market Share by Application (2021-2032)
- 7.2 Global Autoimmunity Reagents Revenue by Application (2021-2032)
- 7.2.1 Global Autoimmunity Reagents Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Autoimmunity Reagents Revenue Market Share by Application (2021-2032)
- 7.3 Global Autoimmunity Reagents Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Autoimmunity Reagents Value Chain Analysis
- 8.1.1 Autoimmunity Reagents Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Autoimmunity Reagents Production Mode & Process
- 8.2 Autoimmunity Reagents Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Autoimmunity Reagents Distributors
- 8.2.3 Autoimmunity Reagents Customers
9 Global Autoimmunity Reagents Analyzing Market Dynamics
- 9.1 Autoimmunity Reagents Industry Trends
- 9.2 Autoimmunity Reagents Industry Drivers
- 9.3 Autoimmunity Reagents Industry Opportunities and Challenges
- 9.4 Autoimmunity Reagents Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst